The Evidence Based Rheumatology Podcast
Health & Fitness:Medicine
This week I go back to a topic from episode 42, the SENSCIS trial and nintedanib for SSc-ILD. The way this medication has been received and a recent article I wrote for The Rheumatologist gave me a nice jumping off point to cover a few more issues from this. Be sure to follow me @EBRheum to let me know what you think! The corresponding article is available here: https://www.the-rheumatologist.org/article/fda-approves-nintedanib-for-ssc-ild-but-temper-your-expectations/
E71: MTX Discontinuation Post... Influenza Vaccination
E70: Rheum4Debate - HCQ Levels Should Be Monitored in Patients with SLE
E69: Publication Trends in SRMAs and RCTs
E68: SELECT-CHOICE Upadacitinib vs Abatacept in RA
E67: Belimumab in Lupus Nephritis (BLISS-LN)
E66: MRI to Diagnose PMR
E65: Anifrolumab in SLE - A Reply
E63: Housekeeping #3
E57: PEXIVAS Trial - PLEX and Reduced Steroid in ANCA Vasculitis
E56: Continue or Withdraw Prednisone in SLE (CORTICOLUP)
E55: Anifrolumab for SLE (TULIP 1&2)
E54: Rheum4Debate - Triple Tx is 1st Line in RA w/No Response to MTX
E52: HOPE RCT - Prednisone for OA of the Hand
E51: Rheum4Debate - "Start TCZ Upfront in GCA"
E50: Housekeeping 2
E49: IL17i vs. TNFi for Psoriatic Arthritis (SPIRIT-H2H)
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
E47: HCQ Blood Levels and HCQ Retinopathy
E46: Rituximab in Lupus
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive